Markers of Eosinophilic Inflammation for Diagnosis of Eosinophilic Esophagitis and Proton Pump Inhibitor-Responsive Esophageal Eosinophilia: A Prospective Study

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 12, 2014, Pages 2015-2022

  Dellon, Evan S ^a   Speck, Olga ^a   Woodward, Kimberly ^a   Covey, Shannon ^a   Rusin, Spencer ^a   Gebhart, Jessica H ^a   Chen, Xiaoxin ^a,b   Woosley, John T ^a   Shaheen, Nicholas J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

AUCROC; Diagnostic; GERD; Immunohistochemical Assay; Validation

Indexed keywords

EOTAXIN 3; MAJOR BASIC PROTEIN; TRYPTASE; BETA CHEMOKINE; BIOLOGICAL MARKER; CCL26 PROTEIN, HUMAN; MBP PROTEIN, HUMAN; MYELIN BASIC PROTEIN; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; ASSAY; CONSENSUS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DYSPHAGIA; ENDOSCOPY; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC INFLAMMATION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PROTON PUMP INHIBITOR RESPONSIVE ESOPHAGEAL EOSINOPHILIA; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STAINING; UNITED STATES; ADOLESCENT; AGED; CHEMICALLY INDUCED; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CHEMOKINES, CC; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYELIN BASIC PROTEIN; NORTH CAROLINA; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; SENSITIVITY AND SPECIFICITY; TRYPTASES; YOUNG ADULT;

EID: 84918815294     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.06.019     Document Type: Article

References (28)

1. Liacouras C.A., Furuta G.T., Hirano I., et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. JAllergy Clin Immunol 2011, 128:3-20.
2. Dellon E.S., Gonsalves N., Hirano I., et al. ACG clinical guideline: evidence based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis. Am J Gastroenterol 2013, 108:679-692.
3. Dellon E.S., Gibbs W.B., Fritchie K.J., et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2009, 7:1305-1313.
4. Rodrigo S., Abboud G., Oh D., et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol 2008, 103:435-442.
5. Dranove J.E., Horn D.S., Davis M.A., et al. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. JPediatr 2009, 154:96-100.
6. Molina-Infante J., Ferrando-Lamana L., Ripoll C., et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 2011, 9:110-117.
7. Dellon E.S., Speck O., Woodward K., et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol 2013, 108:1854-1860.
8. Dellon E.S., Chen X., Miller C.R., et al. Tryptase staining of mastcells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol 2011, 106:264-271.
9. Dellon E.S., Chen X., Miller C.R., et al. Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis. Am J Gastroenterol 2012, 107:1503-1511.
10. Gonsalves N., Policarpio-Nicolas M., Zhang Q., et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006, 64:313-319.
11. Dellon E.S., Fritchie K.J., Rubinas T.C., et al. Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia. Dig Dis Sci 2010, 55:1940-1949.
12. Dellon E.S., Aderoju A., Woosley J.T., et al. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol 2007, 102:2300-2313.
13. Dellon E.S., Bower J.J., Keku T.O., et al. Markers of tyrosine kinase activity in eosinophilic esophagitis: a pilot study of the FIP1L1-PDGFRalpha fusion gene, pERK 1/2, and pSTAT5. Dis Esophagus 2012, 25:166-174.
14. Bhattacharya B., Carlsten J., Sabo E., et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis andgastroesophageal reflux disease. Hum Pathol 2007, 38:1744-1753.
15. Blanchard C., Stucke E.M., Rodriguez-Jimenez B., et al. Astriking local esophageal cytokine expression profile in eosinophilic esophagitis. JAllergy Clin Immunol 2011, 127:208-217.
16. Blanchard C., Wang N., Stringer K.F., et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. JClin Invest 2006, 116:536-547.
17. Gupta S.K., Fitzgerald J.F., Kondratyuk T., et al. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. JPediatr Gastroenterol Nutr 2006, 42:22-26.
18. Justinich C.J., Ricci A., Kalafus D.A., et al. Activated eosinophils in esophagitis in children: a transmission electron microscopic study. JPediatr Gastroenterol Nutr 1997, 25:194-198.
19. Lucendo A.J., Navarro M., Comas C., et al. Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus. Am J Surg Pathol 2007, 31:598-606.
20. Mueller S., Aigner T., Neureiter D., et al. Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy. JClin Pathol 2006, 59:1175-1180.
21. Mueller S., Neureiter D., Aigner T., et al. Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material. Histopathology 2008, 53:676-684.
22. Colombo J.M., Neilan N.A., Schurman J.V., et al. Validation of methods to assess potential biomarkers in pediatric patients with esophageal eosinophilia. World J Gastrointest Pharmacol Ther 2013, 4:113-119.
23. Abonia J.P., Blanchard C., Butz B.B., et al. Involvement of mast cells in eosinophilic esophagitis. JAllergy Clin Immunol 2010, 126:140-149.
24. Straumann A., Bauer M., Fischer B., et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. JAllergy Clin Immunol 2001, 108:954-961.
25. Kirsch R., Bokhary R., Marcon M.A., et al. Activated mucosal mastcells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. JPediatr Gastroenterol Nutr 2007, 44:20-26.
26. Molina-Infante J., Rivas M.D., Rodriguez G.V., et al. Remission in proton pump inhibitors-responsive esophageal eosinophilia correlates with downregulation of eotaxin-3 and TH2 cytokines, similarly to eosinophilic esophagitis after steroids. Gastroenterology 2013, 144(Suppl 1). S484 (Su1828).
27. Veerappan G.R., Perry J.L., Duncan T.J., et al. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol 2009, 7:420-426.
28. Moawad F.J., Veerappan G.R., Dias J.A., et al. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia. Am J Gastroenterol 2013, 108:366-372.